Reuters exclusively reported that a World Health Organization-led program to ensure poorer countries get fair access to COVID-19 vaccines, tests and treatments aims to secure antiviral drugs for patients with mild symptoms for as little as $10 per course. Merck & Co’s experimental pill molnupiravir is likely to be one of the drugs, and other drugs to treat mild patients are being developed. According to a draft document seen by Reuters, which outlines the goals of the Access to COVID-19 Tools Accelerator (ACT-A) until September next year, the program wants to deliver about 1 billion COVID-19 tests to poorer nations and procure drugs to treat up to 120 million patients globally, out of about 200 million new cases it estimates in the next 12 months.
Business & FinanceHealth
Reuters exclusively reports WHO-led program aims to buy antiviral COVID-19 pills for $10
19 October 2021, 2:16 pm 1 minute
Article Tags
Topics of Interest: Business & FinanceHealth
Type: Reuters Best
Sectors: Pharmaceuticals & Healthcare
Regions: Global
Win Types: Exclusivity
Story Types: Exclusive / Scoop
Media Types: Text
Customer Impact: Major Global Story